These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8077802)

  • 21. A comparative study of the blockade of calcium-dependent action potentials by verapamil, nifedipine and nimodipine in ventricular muscle.
    Hachisu M; Pappano AJ
    J Pharmacol Exp Ther; 1983 Apr; 225(1):112-20. PubMed ID: 6834265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed].
    Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M
    Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of erythropoietin on blood pressure.
    Raine AE; Roger SD
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):76-83. PubMed ID: 1928084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin has no direct or strong vasoconstrictor effects in vivo and in vitro.
    Takahashi S; Yanai M; Okada K
    Nephrol Dial Transplant; 1995; 10(6):815-20. PubMed ID: 7566609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actions of calcium antagonists on calcium currents in Helix neurons. Specificity and potency.
    Nishi K; Akaike N; Oyama Y; Ito H
    Circ Res; 1983 Feb; 52(2 Pt 2):I53-9. PubMed ID: 6131753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin.
    Horina JH; Schwaberger G; Brussee H; Sauseng-Fellegger G; Holzer H; Krejs GJ
    Nephrol Dial Transplant; 1993; 8(11):1219-22. PubMed ID: 8302459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist.
    Shibata S; Wakabayashi S; Satake N; Hester RK; Ueda S; Tomiyama A
    J Pharmacol Exp Ther; 1987 Jan; 240(1):16-22. PubMed ID: 3100766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ca(2+)-channel blockers and binding of tricyclic antidepressive agents].
    Krulík R; Bures P; Fisar Z; Fuksová K; Sikora J; Beitlová D
    Cesk Psychiatr; 1995 Jul; 91(3):143-51. PubMed ID: 7553947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of increased extracellular calcium concentration on the hypoxic and pharmacologic hyperemia of skeletal muscle].
    Meyer VU; Marten W; Schiffer W; Raff WK
    Arzneimittelforschung; 1975 May; 25(5):749-53. PubMed ID: 1242316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
    Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction.
    Andrawis NS; Craft N; Abernethy DR
    J Pharmacol Exp Ther; 1992 Jun; 261(3):879-84. PubMed ID: 1602392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells.
    Carlini RG; Gupta A; Liapis H; Rothstein M
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):889-92. PubMed ID: 8606524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation?
    Buemi M; Allegra A; Laganà A; Aloisi C; Morabito N; Baldari S; Privitera M; Palella S; Imbesi D; Villari C
    Int Angiol; 1994 Mar; 13(1):75-7. PubMed ID: 8077802
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.